Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Complications of Diabetes 2017.

Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M.

J Diabetes Res. 2018 Mar 11;2018:3086167. doi: 10.1155/2018/3086167. eCollection 2018. No abstract available.

2.

Complications of Diabetes 2016.

Papatheodorou K, Papanas N, Banach M, Papazoglou D, Edmonds M.

J Diabetes Res. 2016;2016:6989453. Epub 2016 Oct 16. No abstract available.

3.

Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes.

Bekiari E, Rizava C, Athanasiadou E, Papatheodorou K, Liakos A, Karagiannis T, Mainou M, Rika M, Boura P, Tsapas A.

Endocrine. 2016 Jun;52(3):458-80. doi: 10.1007/s12020-015-0841-1. Epub 2015 Dec 29. Review.

PMID:
26714458
4.

Complications of Diabetes.

Papatheodorou K, Banach M, Edmonds M, Papanas N, Papazoglou D.

J Diabetes Res. 2015;2015:189525. doi: 10.1155/2015/189525. Epub 2015 Jul 12. No abstract available.

5.

Debilitating chronic diarrhea caused by generalized gastrointestinal cytomegalovirus infection in an immunocompetent adult.

Telakis E, Tsironi E, Papatheodorou K, Nikolakis D.

Case Rep Gastrointest Med. 2014;2014:260120. doi: 10.1155/2014/260120. Epub 2014 Jun 12.

6.

Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis.

Liakos A, Karagiannis T, Athanasiadou E, Sarigianni M, Mainou M, Papatheodorou K, Bekiari E, Tsapas A.

Diabetes Obes Metab. 2014 Oct;16(10):984-93. doi: 10.1111/dom.12307. Epub 2014 May 28. Review.

PMID:
24766495
7.

Determinants of microbial load in infected diabetic foot ulcers: a pilot study.

Demetriou M, Papanas N, Panopoulou M, Papatheodorou K, Maltezos E.

Int J Endocrinol. 2013;2013:858206. doi: 10.1155/2013/858206. Epub 2013 Jun 26.

8.

Tissue and swab culture in diabetic foot infections: neuropathic versus neuroischemic ulcers.

Demetriou M, Papanas N, Panopoulou M, Papatheodorou K, Bounovas A, Maltezos E.

Int J Low Extrem Wounds. 2013 Jun;12(2):87-93. doi: 10.1177/1534734613481975. Epub 2013 May 9.

PMID:
23667099
9.

Anatomic variations of the right hepatic duct: results and surgical implications from a cadaveric study.

Mariolis-Sapsakos T, Kalles V, Papatheodorou K, Goutas N, Papapanagiotou I, Flessas I, Kaklamanos I, Arvanitis DL, Konstantinou E, Sgantzos MN.

Anat Res Int. 2012;2012:838179. doi: 10.1155/2012/838179. Epub 2012 Sep 29.

10.

Uncoupling protein-2 45-base pair insertion/deletion polymorphism: is there an association with severe obesity and weight loss in morbidly obese subjects?

Papazoglou D, Papathanasiou P, Papanas N, Papatheodorou K, Chatziangeli E, Nikitidis I, Kotsiou S, Maltezos E.

Metab Syndr Relat Disord. 2012 Aug;10(4):307-11. doi: 10.1089/met.2012.0003. Epub 2012 May 8.

PMID:
22568573
11.

Monocyte chemoattractant protein 1 is correlated with glycemic control and peripheral arterial disease in type 2 diabetic patients with metabolic syndrome.

Papatheodorou K, Papanas N, Papazoglou D, Gioka T, Antonoglou C, Glaros D, Maltezos E.

Angiology. 2013 Apr;64(3):223-9. doi: 10.1177/0003319712440143. Epub 2012 Apr 9.

PMID:
22492254
12.

Serotonin receptor 2A -1438G/A promoter polymorphism in relation to obesity and response to sibutramine.

Papazoglou D, Restas E, Papanas N, Papatheodorou K, Babouris C, Glaros D, Antonoglou C, Maltezos E.

Genet Test Mol Biomarkers. 2012 Feb;16(2):109-12. doi: 10.1089/gtmb.2011.0133. Epub 2011 Oct 6.

PMID:
21977970
13.

Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus.

Papanas N, Demetriou M, Katsiki N, Papatheodorou K, Papazoglou D, Gioka T, Kotsiou S, Maltezos E, Mikhailidis DP.

Exp Diabetes Res. 2011;2011:346051. doi: 10.1155/2011/346051. Epub 2011 Sep 15.

14.

Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes.

Papanas N, Paschos P, Papazoglou D, Papatheodorou K, Paletas K, Maltezos E, Tsapas A.

Diabetes Care. 2011 Jun;34(6):1378-82. doi: 10.2337/dc10-2205. Epub 2011 Apr 19.

15.

Evaluation of a new foam to increase skin hydration of the foot in type 2 diabetes: a pilot study.

Papanas N, Papazoglou D, Papatheodorou K, Maltezos E.

Int Wound J. 2011 Jun;8(3):297-300. doi: 10.1111/j.1742-481X.2011.00786.x. Epub 2011 Mar 30.

PMID:
21449930
16.

Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus.

Papanas N, Katsiki N, Papatheodorou K, Demetriou M, Papazoglou D, Gioka T, Maltezos E.

Angiology. 2011 May;62(4):291-5. doi: 10.1177/0003319710394164. Epub 2011 Feb 8.

PMID:
21306998
17.

A prospective study on the use of the indicator test Neuropad® for the early diagnosis of peripheral neuropathy in type 2 diabetes.

Papanas N, Papatheodorou K, Papazoglou D, Kotsiou S, Maltezos E.

Exp Clin Endocrinol Diabetes. 2011 Feb;119(2):122-5. doi: 10.1055/s-0030-1261934. Epub 2010 Aug 5.

PMID:
20690070
18.

Association between foot temperature and sudomotor dysfunction in type 2 diabetes.

Papanas N, Papatheodorou K, Papazoglou D, Kotsiou S, Maltezos E.

J Diabetes Sci Technol. 2010 Jul 1;4(4):803-7.

19.

Lanarkshire Oximetry Index as a diagnostic tool for peripheral arterial disease in type 2 diabetes: a pilot study.

Papanas N, Kakagia D, Papatheodorou K, Papazoglou D, Alexandridou M, Pagkalos A, Karadimas EJ, Maltezos E.

Angiology. 2010 May;61(4):388-91. doi: 10.1177/0003319709358696.

PMID:
20483811
20.

Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 levels in severely obese patients: what is the effect of weight loss?

Papazoglou D, Papatheodorou K, Papanas N, Papadopoulos T, Gioka T, Kabouromiti G, Kotsiou S, Maltezos E.

Exp Clin Endocrinol Diabetes. 2010 Nov;118(10):730-4. doi: 10.1055/s-0030-1249671. Epub 2010 Apr 1.

PMID:
20361393

Supplemental Content

Loading ...
Support Center